INCREASED SEVERITY OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN RATS TOLERIZED AS ADULTS BUT NOT NEONATALLY TO A PROTECTIVE TCR V-BETA-8CDR2 IDIOTOPE
H. Offner et al., INCREASED SEVERITY OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN RATS TOLERIZED AS ADULTS BUT NOT NEONATALLY TO A PROTECTIVE TCR V-BETA-8CDR2 IDIOTOPE, The Journal of immunology, 154(2), 1995, pp. 928-935
The ability of synthetic V region peptides to induce regulatory T cell
s and Abs in rodents and humans provides clear evidence that these idi
otopes do not naturally induce tolerance. In this study, we investigat
ed the ability of TCR V beta 8.2 peptides to experimentally induce spe
cific T cell tolerance, as measured by loss of Ag-specific proliferati
on and delayed-type hypersensitivity responses, and by increased susce
ptibility to experimental autoimmune encephalomyelitis (EAE). We found
that both neonatal and adult exposure to V beta 8.2-39-59 or V beta 8
-44-54 peptides could induce efficient T cell tolerance, resulting in
a significant inhibition of peptide-specific proliferative responses.
In addition, neonatal tolerance resulted in a partial reduction in del
ayed-type hypersensitivity response and an inability to vaccinate agai
nst EAE after adult immunization with the tolerizing peptide. We furth
er evaluated the contribution of naturally induced TCR-specific respon
ses to EAE resistance induced by challenging neonatally or adult toler
ized rats with myelin basic protein in adjuvant. The clinical course o
f EAE was not significantly altered in rats tolerized neonatally to V
beta 8.2 peptides, but both the severity and incidence of mortality fr
om EAE was increased in rats tolerized as adults with V beta 8.2 pepti
des conjugated to syngeneic splenocytes. These results demonstrate tha
t V beta 8.2 peptides are tolerogenic as well as immunogenic. Moreover
, the observation of different effects of neonatal vs adult tolerizati
on on the course of EAE suggests either the emergence of additional pr
otective idiotopes after neonatal tolerization and/or mechanistic diff
erences in the two tolerance-inducing protocols. Most importantly, the
enhancement of clinical EAE in rats tolerized as adults with V beta 8
.2 peptides provides evidence for an innate regulatory role of the CDR
2 idiotope in recovery from EAE.